Skip to main content
. 2020 Feb 29;39(3):128–136. doi: 10.12938/bmfh.2020-002

Fig. 8.

Fig. 8.

Pre-administration of MP-G4 protected vancomycin (VCM)-treated mice against CDI. (a) Mouse survival over time after CDI in C57BL/6J female mice treated with water (Ctr), MP-G4, VCM, or VCM with MP-G4 (n=6 per group). (b) Pathogen loads [CFU/g] in feces were detected 1 day after infection. Each dot represents an individual mouse. L.o.D.: limit of detection. (c) ELISA measurement of lipocalin-2 in feces from C. difficile-infected mice from each group (n=6 per group). *p<0.05; ***p<0.001. Data are representative of two independent experiments.